These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 276416
1. Central nervous system involvement at presentation in the chronic phase of chronic myelogenous leukemia in childhood. Meyer RJ, Cuttner J. Cancer; 1978 Jul; 42(1):305-10. PubMed ID: 276416 [Abstract] [Full Text] [Related]
2. Simultaneous meningeal and testicular lymphoblastic transformation of Ph1-positive chronic myelocytic leukaemia in a three-year-old boy. Carlsen NL, Erichsen G, Lisse I. Anticancer Res; 1990 Jul; 10(6):1739-41. PubMed ID: 2285252 [Abstract] [Full Text] [Related]
3. Meningeal leukaemia in the blastic phase of chronic granulocytic leukaemia. Van Bever H, Benoit Y, Delbeke MJ, Orye E. Eur J Pediatr; 1985 Nov; 144(4):417-8. PubMed ID: 3865773 [Abstract] [Full Text] [Related]
4. Therapy of chronic myeloid leukemia (CML): interim report on protocols CML/73 and CML/74. Baccarani M, Ruggero D, Tura S. Boll Ist Sieroter Milan; 1978 Jul 31; 57(3):278-88. PubMed ID: 367386 [Abstract] [Full Text] [Related]
5. Meningeal leukemia after blastic transformation of chronic myeloid leukemia. Atkinson K, Kay HE, Lawler SD, Wells DG, McElwain TJ. Cancer; 1975 Feb 31; 35(2):529-33. PubMed ID: 1053938 [Abstract] [Full Text] [Related]
6. Non-blastic meningeal leukemia during the myelofibrotic phase of chronic myeloid leukemia. Aversa P, Rambotti P, Falini B, Grignani F, Martelli MF. Folia Haematol Int Mag Klin Morphol Blutforsch; 1981 Feb 31; 108(1):72-5. PubMed ID: 6164616 [Abstract] [Full Text] [Related]
7. Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapy. Rytting ME, Wierda WG. Leuk Lymphoma; 2004 Aug 31; 45(8):1623-6. PubMed ID: 15370215 [Abstract] [Full Text] [Related]
8. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate. Pfeifer H, Wassmann B, Hofmann WK, Komor M, Scheuring U, Brück P, Binckebanck A, Schleyer E, Gökbuget N, Wolff T, Lübbert M, Leimer L, Gschaidmeier H, Hoelzer D, Ottmann OG. Clin Cancer Res; 2003 Oct 15; 9(13):4674-81. PubMed ID: 14581336 [Abstract] [Full Text] [Related]
9. Experience on the treatment of chronic myelocytic leukaemia (CML) in blastic crisis. Mandelli F, Amadori S, Alimena G, Annino L, Nardelli S, Papa G. Scand J Haematol; 1977 Nov 15; 19(5):496-502. PubMed ID: 271352 [Abstract] [Full Text] [Related]
10. Bilineal Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia: A Case Report and Literature Review. Gao X, Li J, Wang L, Lin J, Jin H, Xu Y, Wang N, Zhao Y, Liu D, Yu L, Wang Q. Am J Case Rep; 2016 Oct 27; 17():793-798. PubMed ID: 27784881 [Abstract] [Full Text] [Related]
11. A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia. Amadori S, Picardi A, Fazi P, Testi AM, Petti MC, Montefusco E, Mandelli F. Leukemia; 1996 May 27; 10(5):766-8. PubMed ID: 8656669 [Abstract] [Full Text] [Related]
12. [Adult form of chronic myelogenous leukemia in childhood--a retrospective analysis of 20 patients]. Creutzig U, Brandeis W, Gerein V, Ritter J, Stollmann B, Kabisch H, Niethammer D, Schellong G. Klin Padiatr; 1985 May 27; 197(3):203-6. PubMed ID: 3859702 [Abstract] [Full Text] [Related]
13. Meningeal leukemia after blastic transformation of chronic myeloid leukemia. Pai VR, Shetty PA. Indian J Cancer; 1984 May 27; 20(6):283-5. PubMed ID: 6590464 [No Abstract] [Full Text] [Related]
14. Ocular complications following blast transformation in chronic myelogenous leukemia. Hendrick AM, Rogers JS, Guliner RJ. Am J Hematol; 1979 May 27; 7(4):389-94. PubMed ID: 296653 [Abstract] [Full Text] [Related]
15. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval. Cohen MH, Johnson JR, Pazdur R. Clin Cancer Res; 2005 Jan 01; 11(1):12-9. PubMed ID: 15671523 [Abstract] [Full Text] [Related]
16. [Clinical significance of cationic proteins of leukocyte lysosomes: cationic leukocyte antigen (CLA) as a marker of blast crisis in chronic myelocytic leukaemia (author's transl)]. Tischendorf FW, Wüst I, Tischendorf MM. Klin Wochenschr; 1977 Jul 15; 55(14):685-93. PubMed ID: 268450 [Abstract] [Full Text] [Related]
17. [Detecting methylation of the calcitonin gene in monitoring treatment and disease evolution for myelogenous leukemia]. Xie XH, Chen ZZ, Zhang XM, Huang MQ. Ai Zheng; 2003 Jun 15; 22(6):616-9. PubMed ID: 12948412 [Abstract] [Full Text] [Related]
18. [Involvement of the central nervous system in chronic myeloid leukemia]. Voglová J, Chrobák L, Radochová D, Mirová S. Vnitr Lek; 1987 Apr 15; 33(4):361-6. PubMed ID: 3473792 [No Abstract] [Full Text] [Related]
19. Cytogenetic studies of chronic myelocytic leukemia in children and adolescents. Hays T, Morse H, Peakman D, Rose B, Robinson A. Cancer; 1979 Jul 15; 44(1):210-4. PubMed ID: 287550 [Abstract] [Full Text] [Related]
20. Isolated meningeal chloroma (granulocytic sarcoma)--a case report and review of the literature. Binder C, Tiemann M, Haase D, Humpe A, Kneba M. Ann Hematol; 2000 Aug 15; 79(8):459-62. PubMed ID: 10985368 [Abstract] [Full Text] [Related] Page: [Next] [New Search]